A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies have launched a Breast Cancer Access Navigation and Testing Programme targeted ...

Swiss pharma giant, Roche, in collaboration with Oncopadi Technologies, has launched a Breast Cancer Access Navigation and Testing Programme ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

The global tumor profiling market share analysis is on a strong growth trajectory, projected to reach USD 11.9 billion by 2025, with a CAGR of 8.3% from 2025 to 2035. This surge is fueled by the ...

Digital Pathology Market 2025 Digital Pathology Market is estimated to be valued at USD 1,112.8 Mn in 2025 and is expected to reach USD 2,4 ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...

Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical ...